HISOAR(SZ:002099)2023-02-17 08:14Group 1: Company Overview - Zhejiang Haixiang Pharmaceutical Co., Ltd. is a global supplier of the penem industry chain, providing high-level intermediates and active pharmaceutical ingredients (APIs) [1] - The company is actively expanding strategic customer collaborations and optimizing customer structure [1] Group 2: Market and Financial Insights - The revenue scale and profitability of the penem series are expected to improve continuously, although there is uncertainty due to market price fluctuations [1] - In 2022, raw material price fluctuations had a significant impact, but the company has implemented various strategies to mitigate these effects, including long-term price locking with suppliers [1] Group 3: CMO/CDMO Developments - The company has seen unexpected growth in new project collaborations, particularly with European clients for Phase III clinical projects [2] - Future capital investments are expected to decrease compared to previous years, focusing on expanding CMO/CDMO capacity and enhancing the sterile system construction [2]